In the present study, four genetically distinct cellular cancer models (breast and cervical cancer, osteosarcoma and glioblastoma cells) were utilized to investigate the impact of DNMT2/TRDMT1 gene knockout on doxorubicin (DOX)-induced ER stress and the UPR. This evidence concerns the gene TRDMT1 and cervical carcinoma.